This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV)
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
Topicsvaccines and immunoinformatics approaches · Transgenic Plants and Applications · Plant Virus Research Studies
The PLOS One Editors retract this article [1,2] due to concerns about peer review integrity and potential manipulation of the publication process. These concerns call into question the validity of the reported results. We regret that the issues were not identified prior to the article’s publication.
MAU, NNI, MAK, and AMS agreed with the retraction. RBP did not agree with the retraction. TZ responded but expressed neither agreement nor disagreement with the editorial decision. ATM, NAR, TBR, NN, SIM, MNS, and NA either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Moin AT, Rani NA, Ullah MA, Patil RB, Robin TB, Nawal N, et al. An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV). P Lo S One. 2023;18(9): e 0287416. doi: 10.1371/journal.pone.0287416 37682972 PMC 10490984 · doi ↗ · pubmed ↗
- 2Moin AT, Rani NA, Ullah MA, Patil RB, Robin TB, Nawal N, et al. Correction: An immunoinformatics and extended molecular dynamics approach for designing a polyvalent vaccine against multiple strains of Human T-lymphotropic virus (HTLV). P Lo S One. 2023;18(12): e 0295830. doi: 10.1371/journal.pone.0295830 38064466 PMC 10707563 · doi ↗ · pubmed ↗